FIELD: genetic engineering, molecular biology. SUBSTANCE: invention can be used in medico-biological industry for preparing medicinal agents for genetic therapy. Invention reports about preparing and characterizing the sequence of human endoglyne gene promoter displaying high specificity with respect to endothelium tissue. Also, fragments of indicates sequence are determined that retain ability to carry out the function of full-sized promoter. Invention proposes nucleotide constructions where gene(s) is located being them transcription is to be activated desirably and this gene is located under control of a new promoter or its active fragment. Medicinal agents used for treatment of many human diseases can be prepared by insertion of proposed constructions into suitable vectors. EFFECT: valuable biological and medicinal properties of gene promoter. 12 cl, 5 dwg, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| GENETICALLY MODIFIED CELLS AND THEIR APPLICATION FOR PROPHYLAXIS OR TREATMENT OF SICKNESSES | 1998 |
|
RU2205029C2 |
| SELF-AMPLIFYING PHARMACOLOGICALLY CONTROLLABLE EXPRESSIVE SYSTEMS | 1997 |
|
RU2197993C2 |
| METHOD FOR APPLYING GENETIC THERAPY OF VASCULAR DISEASES BY MEANS OF ACTIVE SUBSTANCE SPECIFIC TO CELL AND DEPENDANT ON CELLULAR CYCLE | 1995 |
|
RU2197992C2 |
| RECEPTORS-MEDIATED DELIVERY OF GENES BY USING VECTORS BASED UPON BACTERIOPHAGES | 1998 |
|
RU2209088C2 |
| NUCLEOTIDE SEQUENCE ABLE TO INHIBIT IL-6 ACTIVITY, PLASMID VECTOR FOR TRANSFECTION INTO MAMMALIAN CELLS, NUCLEOTIDE SEQUENCE USED IN THERAPY, PHARMACEUTICAL COMPOSITION (VARIANTS) | 1995 |
|
RU2205874C2 |
| RECOMBINANT LENTIVIRAL VECTOR, HOST CELL TRANSDUCED WITH LENTIVIRAL VECTOR, METHODS FOR TRANSDUCTION AND USES THEREOF | 2002 |
|
RU2305708C2 |
| IMPROVING GENETIC CONSTRUCTS FOR PROVIDING HIGH EFFICACY OF ANTI-HIV THERAPY | 2013 |
|
RU2533817C1 |
| AGENT FOR GENE THERAPY OF MALIGNANT GROWTHS | 2010 |
|
RU2447150C1 |
| MULTIPURPOSE CANCER-SPECIFIC PROMOTERS AND USING THEM IN ANTI-CANCER THERAPY | 2013 |
|
RU2539764C2 |
| METHODS AND COMPONENTS FOR INDUCTION OF TUMOR- -SPECIFIC CYTOTOXICITY | 1998 |
|
RU2214280C2 |
